文献速递神经胸部CT

疑似卒中或头部外伤的CT检查:是否值得额外加做胸部CT筛查COVID-19感染

CT Scanning in Suspected Stroke or Head Trauma: Is it Worth Going the Extra Mile and Including the Chest to Screen for COVID-19 Infection?
PubMed 文献 · AJNR Am J Neuroradiol · 2020-05-21

研究纳入27例因疑似卒中或头部外伤行头部CT的患者,额外加做胸部CT并以实时逆转录聚合酶链反应为参考标准检测COVID-19。胸部CT敏感度85.7%、特异度75.0%、阴性预测值93.8%、阳性预测值54.6%。结论认为额外胸部CT敏感度较高,但阴性结果不能排除COVID-19,阳性预测值较差,需结合流行病学史、临床表现及实时逆转录聚合酶链反应确认。

要点

  • 胸部CT检测COVID-19敏感度85.7%、特异度75.0%,阴性预测值93.8%、阳性预测值54.6%。
  • 胸部CT阴性结果不能排除COVID-19,阳性预测值较差。
  • 胸部CT结果需结合流行病学史、临床表现及实时逆转录聚合酶链反应确认。

核心结论

  • 额外胸部CT的敏感度相当高,但阴性结果不能排除COVID-19,阳性预测值较差。
  • 胸部CT结果需与流行病学史和临床表现相关联,并结合实时逆转录聚合酶链反应进行确认。

研究设计与样本

  • 研究纳入27例患者,平均年龄74岁(范围54-90岁),其中男性20例。
  • 患者因疑似卒中(n=21)或头部外伤(n=6)行头部CT,并额外行胸部CT检测COVID-19,同时行实时逆转录聚合酶链反应检测。
  • 研究在COVID-19流行区进行,计算了胸部CT检测COVID-19的敏感度、特异度、阴性预测值和阳性预测值。

诊断标准与关键数值

  • 胸部CT检测COVID-19:敏感度85.7%,特异度75.0%,阴性预测值93.8%,阳性预测值54.6%。
  • 胸部CT结果:真阳性6例、真阴性15例、假阳性5例、假阴性1例。
  • 7/27例(26%)患者经实时逆转录聚合酶链反应确诊COVID-19感染。

临床应用与阅片要点

  • 在COVID-19流行区,对因疑似卒中或头部外伤行头部CT的患者可额外加做胸部CT检测COVID-19。
  • 胸部CT阴性结果不能排除COVID-19,阳性预测值较差。
  • 胸部CT结果需结合流行病学史、临床表现及实时逆转录聚合酶链反应确认。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Chest CT may be used as a tool for rapid coronavirus disease 2019 (COVID-19) detection. Our aim was to investigate the value of additional chest CT for detection of coronavirus 19 (COVID-19) in patients who undergo head CT for suspected stroke or head trauma in a COVID-19-endemic region.

MATERIALS AND METHODS: Our study included 27 patients (mean age, 74 years; range, 54-90 years; 20 men) who underwent head CT for suspected stroke (n = 21) or head trauma (n = 6), additional chest CT for COVID-19 detection, and real-time reverse transcriptase polymerase chain reaction testing in a COVID-19-endemic region. Sensitivity, specificity, and negative and positive predictive values of chest CT in detecting COVID-19 were calculated.

RESULTS: Final neurologic diagnoses were ischemic stroke (n = 11), brain contusion (n = 5), nontraumatic intracranial hemorrhage (n = 2), brain metastasis (n = 1), and no primary neurologic disorder (n = 8). Symptoms of possible COVID-19 infection (ie, fever, cough, and/or shortness of breath) were present in 20 of 27 (74%) patients. Seven of 27 patients (26%) had real-time reverse transcriptase polymerase chain reaction confirmed-COVID-19 infection. Chest CT results were 6 true-positives, 15 true-negatives, 5 false-positives, and 1 false-negative. Diagnostic performance values of chest CT were a sensitivity of 85.7%, specificity of 75.0%, negative predictive value of 93.8%, and positive predictive value of 54.6%.

CONCLUSIONS: The sensitivity of additional chest CT is fairly high. However, a negative result does not exclude COVID-19. The positive predictive value is poor. Correlation of chest CT results with epidemiologic history and clinical presentation, along with real-time reverse transcriptase polymerase chain reaction, is needed for confirmation.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Kwee RM, Krdzalic J, Fasen BACM, et al. CT Scanning in Suspected Stroke or Head Trauma: Is it Worth Going the Extra Mile and Including the Chest to Screen for COVID-19 Infection? AJNR Am J Neuroradiol. 2020. PMID: 32439651. doi:10.3174/ajnr.A6607

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。